RG1122627/GI-003
A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
1959 NE Pacific Street
Seattle, WA 98195
206.598.4100
1354 Aloha Street
Seattle, WA 98109
855.557.0555
1570 N. 115th Street
Seattle, WA 98133
https://www.fredhutch.org/en/patient-care/treatments/proton-therapy.html 206.306.2800
Dr. Apisarnthanarax is a radiation oncologist with expertise in gastrointestinal cancers and genitourinary tumors, including prostate cancer. He also specializes in proton therapy, stereotactic body radiation therapy, and liver cancer.
“Being diagnosed with and treated for cancer is one of the most arduous journeys that any person will experience. Every patient and every cancer is different. As a radiation oncologist, my goal is to guide patients through this difficult time by providing the most compassionate, personalized care possible and making sure they have access to the latest, innovative clinical trials and state-of-art technology.”
College: Brown University, Providence, RI, 1998
Medical Education: Brown University Warren Alpert Medical School, Providence, RI, 2002
Internship: Northwestern University – Evanston Hospital, Evanston, IL, 2003
Fellowship: Experimental Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX, 2005
Residency: Radiation Oncology, University of North Carolina, Chapel Hill, NC, 2009
A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Functional liver imaging with sulfur colloid SPECT/CT in primary and metastatic liver cancer patients receiving liver-directed treatment: a pilot study
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD